<unk>  is used for the treatment of generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Specifically it is only recommended in those who have the condition without an underlying cause, such as medical, psychiatric, or relationship problems. It should be used at least 45 minutes before anticipated sexual activity. Only one dose per 24 hours or no more than eight doses per month is recommended. It should be stopped after eight weeks if there is no improvement in sexual desire and associated distress.
Bremelanotide
Rivastigmine
Carbidopa/levodopa
Tianeptine
Donepezil
Glysobuzole
Glybuzole
Fluorodopa